Skip to main content

Advertisement

SpringerLink
Log in

Secondary haploidentical hematopoietic stem cell transplantation in patients with relapse or graft failure after initial hematopoietic stem cell transplantation

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1

References

  1. Shaw BE, Mufti GJ, Mackinnon S, Cavenagh JD, Pearce RM, Towlson KE, Apperley JF, Chakraverty R, Craddock CF, Kazmi MA, Littlewood TJ, Milligan DW, Pagliuca A, Thomson KJ, Marks DI, Russell NH (2008) Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of hematopoietic malignancy after an initial allogeneic transplant. Bone Marrow Transplant 42:783–789

    Article  CAS  Google Scholar 

  2. Al-Qurashi F, Ayas M, Al Sharif F, Ibrahim E, Sahovic E, Al Mahr M, Chaudhri N, Al Mohareb F, Al Zahrani H, Al Jefri A, Al Omar H, Al Shanqeeti A, Seth P, Aslam M, El Solh H, Aljurf M (2004) Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution. Hematology 9:123–129

    Article  CAS  Google Scholar 

  3. Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang M-J, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, de Lima M (2004) Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant 34:721–727

    Article  CAS  Google Scholar 

  4. Christopeit M, Kuss O, Finke J, Bacher U, Beelen DW, Bornhauser M, Schwerdtfeger R, Bethge WA, Basara N, Gramatzki M, Tischer J, Kolb HJ, Uharek L, Meyer RG, Bunjes D, Scheid C, Martin H, Niederwieser D, Kroger N, Bertz H, Schrezenmeier H, Schmid C (2013) Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change. J Clin Oncol 31:3259–3271

    Article  Google Scholar 

  5. Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, Zoellner AK, Bücklein V, Lippl S, Reibke R, Rieger CT, Ledderose G, Stemmler HJ, Hiddemann W, Schmid C, Hausmann A (2014) Second hematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation. Bone Marrow Transplant 49:895–901

    Article  CAS  Google Scholar 

  6. Xu L, Chen H, Chen J, Han M, Huang H, Lai Y, Liu D, Liu Q, Liu T, Jiang M, Ren H, Song Y, Sun Z, Wang J, Wu D, Zhou D, Zou P, Liu K, Huang X (2018) The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol 11:33

    Article  Google Scholar 

  7. Lorentino F, Labopin M, Bernardi M, Ciceri F, Socie G, Cornelissen JJ, Esteve J, Ruggeri A, Volin L, Yacoub-Agha I, Craddock C, Passweg J, Blaise D, Gedde-Dahl T, Poiani M, Fegueux N, Mohty M, Nagler A (2018) Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission. Am J Hematol 93:1236–1244

    Article  Google Scholar 

  8. Kwon M, Bautista G, Balsalobre P, Sánchez-Ortega I, Montesinos P, Bermúdez A, de Laiglesia A, Herrera P, Martin C, Humala K, Zabalza A, Torres M, Bento L, Corral LL, Heras I, Serrano D, Buño I, Anguita J, Regidor C, Duarte R, Cabrera R, Gayoso J, Diez-Martin JL (2017) Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML. Bone Marrow Transplant 52:1138–1143

    Article  CAS  Google Scholar 

  9. Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF, Huff CA, Matsui W, Bolanos-Meade J, Borrello I, Powell JD, Harrington E, Warnock S, Flowers M, Brodsky RA, Sandmaier BM, Storb RF, Jones RJ, Fuchs EJ (2008) HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 14:641–650

    Article  CAS  Google Scholar 

  10. Michallet M, Tanguy ML, Socié G, Thiébaut A, Belhabri A, Milpied N, Reiffers J, Kuentz M, Cahn JY, Blaise D, Demeocq F, Jouet JP, Michallet AS, Ifrah N, Vilmer E, Molina L, Michel G, Lioure B, Cavazzana-Calvo M, Pico JL, Sadoun A, Guyotat D, Attal M, Curé H, Bordigoni P, Sutton L, Buzyn-Veil A, Tilly M, Keoirruer N, Feguex N (2000) Second allogeneic hematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol 108:400–407

    Article  CAS  Google Scholar 

Download references

Funding

This work has been supported by grants from The National Key Natural Science Foundation of China (81730003, 81870120), The Natural Science Foundation of Jiangsu Province (BK20171205), The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), The Innovation Capability Development Project of Jiangsu Province (no. BM2015004), and The National Key Research and Development Program (2016YFC0902800, 2017YFA0104500).

Author information

Author notes

  1. Chang Hou and Nan Chen contributed equally to this work.

Authors and Affiliations

  1. Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu, People’s Republic of China

    Chang Hou, Nan Chen, Shuhui Jiang, Sifan Chen, Yi Fan, Jia Chen, Ying Wang, Yang Xu & Depei Wu

  2. Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People’s Republic of China

    Yang Xu & Depei Wu

Authors
  1. Chang Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuhui Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sifan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jia Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ying Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Depei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Dr. Depei Wu and Yang Xu contributed to the conception of the study and manuscript revision. Chang Hou and Nan Chen contributed to collecting and performing data analysis and preparing the manuscript. Jia Chen and Yi Fan helped collect and perform data analysis and prepare the manuscript. Shuhui Jiang and Sifan Chen contributed to data analysis and manuscript revision.

Corresponding authors

Correspondence to Yang Xu or Depei Wu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hou, C., Chen, N., Jiang, S. et al. Secondary haploidentical hematopoietic stem cell transplantation in patients with relapse or graft failure after initial hematopoietic stem cell transplantation. Ann Hematol 98, 2833–2836 (2019). https://doi.org/10.1007/s00277-019-03840-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03840-6

Search

Navigation